CA1341444C - Activateur tissulaire du plasminogene modifie - Google Patents
Activateur tissulaire du plasminogene modifie Download PDFInfo
- Publication number
- CA1341444C CA1341444C CA000528043A CA528043A CA1341444C CA 1341444 C CA1341444 C CA 1341444C CA 000528043 A CA000528043 A CA 000528043A CA 528043 A CA528043 A CA 528043A CA 1341444 C CA1341444 C CA 1341444C
- Authority
- CA
- Canada
- Prior art keywords
- domain
- region
- fibrin
- cells
- kringle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82200586A | 1986-01-24 | 1986-01-24 | |
| US06/822,005 | 1986-01-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1341444C true CA1341444C (fr) | 2003-10-21 |
Family
ID=25234849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000528043A Expired - Lifetime CA1341444C (fr) | 1986-01-24 | 1987-01-23 | Activateur tissulaire du plasminogene modifie |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2518832B2 (fr) |
| CA (1) | CA1341444C (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0827751B1 (fr) * | 1996-09-06 | 2003-02-26 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Composition médicinale qui contient de l'activateur de plasminogène tissulaire et de la nicotinamide |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8508717D0 (en) * | 1985-04-03 | 1985-05-09 | Beecham Group Plc | Composition |
| GB8508972D0 (en) * | 1985-04-04 | 1985-05-09 | Beecham Group Plc | Compounds |
| NZ217331A (en) * | 1985-08-26 | 1989-05-29 | Lilly Co Eli | Tissue plasminogen activator derivatives and genetically engineered product |
| JPS63501841A (ja) * | 1985-12-20 | 1988-07-28 | ジ・アップジョン・カンパニ− | 組織プラスミノ−ゲンアクチベ−タ−（ｔｐａ）同族体 |
-
1987
- 1987-01-23 CA CA000528043A patent/CA1341444C/fr not_active Expired - Lifetime
- 1987-01-24 JP JP62015053A patent/JP2518832B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2518832B2 (ja) | 1996-07-31 |
| JPS63133988A (ja) | 1988-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0092182B1 (fr) | Préparation de polypeptides fonctionnelles d'urokinase humaine | |
| EP0178105B1 (fr) | Techniques d'ADN recombinant et produits ainsi obtenus | |
| EP0231624B1 (fr) | Analogues de l'activateur de plasminogène de tissu | |
| JP2610783B2 (ja) | ポリクリングルプラスミノーゲン活性化因子をコードする遺伝子およびそれを含有するベクター | |
| EP0292009A1 (fr) | Protéines fibrinolytiques | |
| EP0234051B1 (fr) | Mutants de l'activateur de plasminogène tissulaire; information recombinante génétique codant pour celui-ci et procédéde préparation de ces mutants, leur application et compositions pharmaceutiques | |
| US5504001A (en) | Hybrid plasminogen activator | |
| US5200340A (en) | Thrombin-activated tissue plasminogen activators | |
| EP0293934B1 (fr) | t-PA mutant avec remplacement de kringle | |
| EP0277313B1 (fr) | Activateur de plasminogène hybride | |
| US5403734A (en) | t-PA with growth factor domain substitutions | |
| US5112755A (en) | Preparation of functional human urokinase proteins | |
| US5073494A (en) | Human tissue plasminogen activator substituted at position 275 or at positions 275 and 277 | |
| WO1989011531A1 (fr) | Variants d'activateurs de plasminogene et leurs procede de production | |
| US5149533A (en) | Modified t-PA with kringle-/replaced by another kringle | |
| EP0299706A2 (fr) | Activateur du plasminogène non glycosyte, et sa méthode de fabrication | |
| CA1341444C (fr) | Activateur tissulaire du plasminogene modifie | |
| US5486471A (en) | Tissue plasminogen activator analogs having modified growth factor domains | |
| US5409700A (en) | Pharmaceutical compositions comprising modified and unmodified plasminogen activators | |
| EP0316068A1 (fr) | Activateur du plasminogène modifié de bas poids moléculaire et méthode pour sa préparation | |
| US5580559A (en) | Hybrid plasminogen activator | |
| US5242819A (en) | DNA molecules encoding hybrid proteins of tissue plasminogen activator and urokinase | |
| US5045315A (en) | Process for treating thrombosis by administering poly-kringle plasminogen activator | |
| GB2121050A (en) | Preparation of functional human urokinase proteins | |
| HU202280B (en) | Process for producing functional human urokinase proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |
Effective date: 20201021 |